Drug
Cg-200745 clinical trials
Also written Ivaltinostat.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
CG Pharmaceuticals, Inc (1) · Machaon Biotherapeutics, Inc. (1) · CrystalGenomics, Inc. (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses cg-200745 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic AdenocarcinomaActive, not recruitingPhase 1/2CG Pharmaceuticals, IncNCT05249101Written as Ivaltinostat
- Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral CapsuleActive, not recruitingPhase 1Machaon Biotherapeutics, Inc.NCT05716919Written as Ivaltinostat
- Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic ProfileStatus unknownPhase 1CrystalGenomics, Inc.NCT01226407Written as CG200745
Codes
What other systems call cg-200745 · ClinicalTrials.gg INT006069
- UNII (FDA) 4I8MLM7L2HIVALTINOSTATConfirmed FDA, Wikidata
- Wikidata Q27259620cg-200745Confirmed FDA, Wikidata
- DrugBank DB12259One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4I8MLM7L2H | IVALTINOSTAT | Confirmed FDA, Wikidata |
| Wikidata | Q27259620 | cg-200745 | Confirmed FDA, Wikidata |
| DrugBank | DB12259 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.